IFN-γ production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine

被引:154
作者
Swanson, MA
Lee, WT
Sanders, VM
机构
[1] Loyola Univ, Med Ctr, Dept Cell Biol, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Microbiol & Immunol, Maywood, IL 60153 USA
[3] Loyola Univ, Med Ctr, Dept Neurobiol, Maywood, IL 60153 USA
[4] Loyola Univ, Med Ctr, Dept Anat, Maywood, IL 60153 USA
[5] Wadsworth Inst, Dept Immunol, Albany, NY 12208 USA
关键词
D O I
10.4049/jimmunol.166.1.232
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During activation in vivo, naive CD4(+) T cells are exposed to various endogenous ligands, such as cytokines and the neurotransmitter norepinephrine (NE), To determine whether NE affects naive T cell differentiation, we used naive CD4(+) T cells sort-purified from either BALB/c or DO11.10 TCR-transgenic mouse spleens and activated these cells with either anti-CD3/anti-CD28 mAbs or APC and OVA(323-329) peptide, respectively, under Th1-promoting conditions. RT-PCR and functional assays using selective adrenergic receptor (AR) subtype antagonists showed that naive CD4+ T cells expressed only the beta (2)AR subtype to bind NE and that stimulation of this receptor generated Th1 cells that produced 2- to 4-fold more IFN-gamma, This increase was due to more IFN-gamma produced per cell upon restimulation instead of more IFN-gamma -secreting cells, as determined by IFN-gamma -specific immunofluorescence and enzyme-linked immunospot, In contrast, Th1 cell differentiation was unaffected when naive T cells were exposed to NE and activated either in the presence of a neutralizing anti-IL-12 mAb or by APC from IL-12-deficient mice. Moreover, the addition of IL-12 to the IL-la-deficient APC cultures restored the ability of NE to increase Th1 differentiation. Taken together, these results indicate that a possible link may exist between the signaling pathways used by NE and IL-12 to increase naive CD4+ T cell differentiation to a Th1 cell.
引用
收藏
页码:232 / 240
页数:9
相关论文
共 40 条
[11]   RESPONSE OF NAIVE ANTIGEN-SPECIFIC CD4+ T-CELLS INVITRO - CHARACTERISTICS AND ANTIGEN-PRESENTING CELL REQUIREMENTS [J].
CROFT, M ;
DUNCAN, DD ;
SWAIN, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1431-1437
[13]  
Fox CJ, 1997, J IMMUNOL, V158, P2414
[14]   NOREPINEPHRINE AND SEROTONIN CONTENT OF THE MURINE SPLEEN - ITS RELATIONSHIP TO LYMPHOCYTE BETA-ADRENERGIC-RECEPTOR DENSITY AND THE HUMORAL IMMUNE-RESPONSE INVIVO AND INVITRO [J].
FUCHS, BA ;
CAMPBELL, KS ;
MUNSON, AE .
CELLULAR IMMUNOLOGY, 1988, 117 (02) :339-351
[15]   T-CELL GENETIC BACKGROUND DETERMINES DEFAULT T-HELPER PHENOTYPE DEVELOPMENT IN-VITRO [J].
HSIEH, CS ;
MACATONIA, SE ;
OGARRA, A ;
MURPHY, KM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :713-721
[16]  
Katamura K, 1998, MOL IMMUNOL, V35, P39
[17]  
KATAMURA K, 1995, J IMMUNOL, V155, P4604
[18]   Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow [J].
Kohm, AP ;
Tang, YM ;
Sanders, VM ;
Jones, SB .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :725-733
[19]   VIRGIN T-CELLS DO NOT PROVIDE HELP FOR ANTIGEN-SPECIFIC B-CELLS IN THE ABSENCE OF IL-4, IL-5, AND IL-6 [J].
LEE, WT ;
VITETTA, ES .
INTERNATIONAL IMMUNOLOGY, 1991, 3 (09) :907-916
[20]  
MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417